Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Cancer Treat Res Commun. 2021;26:100287. doi: 10.1016/j.ctarc.2020.100287. Epub 2020 Dec 17.
Chemoradiation (CRT) with intensity modulated radiation treatment (IMRT) has become the standard for anal cancer. In patients who fail this treatment modality, salvage surgery with abdominal perineal resection can result in long term cancer control. We aimed to evaluate a single centre's experience of salvage surgery for local recurrence since the introduction of IMRT.
A retrospective chart review was performed of all patients who underwent definitive CRT for anal carcinoma at a single tertiary referral center since IMRT became standard in 2009. Patients with recurrent or persistent disease after treatment who underwent salvage surgery were included. Details of CRT, salvage surgery and surgical complications, patterns of recurrence after surgery, and survival data were collected and described.
Between 2009-2018, 181 patients underwent definitive treatment using IMRT for anal carcinoma. Of 26 patients who had locoregional recurrent or persistent disease, 14 underwent salvage surgery. Nine had multi-visceral resection and 8 required autologous flap reconstruction. Twelve patients had resections with clear margins and 2 had microscopic positive margins. Twelve patients (86%) experienced post-operative complications, and eight (57%) had perineal wound complications. After salvage, four patients (29%) recurred locally. None of the 8 patients with rpT2 disease recurred. After salvage surgery, 5-year disease free survival was 68.4% and 5-year overall survival was 75%.
Following IMRT based chemoradiation, salvage surgery has high rates of surgical complications; however disease free and overall survival results are excellent particularly for small recurrences.
采用调强放射治疗(IMRT)的放化疗(CRT)已成为肛门癌的标准治疗方法。在这种治疗方式失败的患者中,采用腹会阴联合切除术进行挽救性手术可实现长期的癌症控制。我们旨在评估自 IMRT 引入以来,单一中心在肛门癌局部复发后行挽救性手术的经验。
我们对 2009 年 IMRT 成为标准治疗方法以来,在一家三级转诊中心接受根治性 CRT 治疗的所有肛门癌患者进行了回顾性图表审查。纳入在治疗后出现复发或持续性疾病并接受挽救性手术的患者。收集并描述了 CRT、挽救性手术和手术并发症、手术后复发模式以及生存数据的详细信息。
2009 年至 2018 年间,181 例患者采用 IMRT 接受了根治性治疗。在 26 例局部复发或持续性疾病的患者中,有 14 例接受了挽救性手术。9 例患者进行了多脏器切除术,8 例患者需要进行自体皮瓣重建。12 例患者的切除切缘清晰,2 例患者的切除切缘有镜下阳性。12 例患者(86%)发生术后并发症,8 例患者(57%)出现会阴伤口并发症。挽救性手术后,4 例患者(29%)局部复发。rpT2 疾病患者无一例复发。行挽救性手术后,5 年无病生存率为 68.4%,5 年总生存率为 75%。
在基于 IMRT 的放化疗后,挽救性手术的手术并发症发生率较高;但无病生存率和总生存率结果非常出色,特别是对于小的复发。